Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical and Translational Radiation Oncology|June 22, 2018
Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-upMaria Antonietta Gambacorta, Antonino De Paoli, Marco Lupattelli, et al.
Diabetes & Metabolism|June 27, 2022
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetesErminia Lembo, Maria Francesca Russo, Ornella Verrastro, et al.
Gut|July 12, 2022
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosisGiulia Angelini, Simona Panunzi, Lidia Castagneto-Gissey, et al.
Lancet (London, England)|April 23, 2023
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trialOrnella Verrastro, Simona Panunzi, Lidia Castagneto-Gissey, et al.
World Journal of Hepatology|January 24, 2018
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinomaFrancesca Romana Ponziani, Irene Spinelli, Emanuele Rinninella, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancerVincenzo Valentini, Maria Antonietta Gambacorta, Francesco Cellini, et al.
Gut|February 5, 2021
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?Ramy Younes, Olivier Govaere, Salvatore Petta, et al.
Pageof 4